AMZ1

Chr 7

archaelysin family metallopeptidase 1

Predicted to enable metal ion binding activity and metallopeptidase activity. Predicted to be involved in proteolysis. [provided by Alliance of Genome Resources, Jul 2025]

OMIMResearchGenerating clinical summary…
LOEUF 1.94
Clinical SummaryAMZ1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.94LOEUF
pLI 0.000
Z-score -2.36
OE 1.61 (1.171.94)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-3.59Z-score
OE missense 1.58 (1.461.70)
485 obs / 307.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?1.61 (1.171.94)
00.351.4
Missense OE?1.58 (1.461.70)
00.61.4
Synonymous OE?1.50
01.21.6
LoF obs/exp: 28 / 17.4Missense obs/exp: 485 / 307.8Syn Z: -4.68

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

AMZ1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →